Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective To compare the effectiveness of glyburide and insulin for the treatment of Gestational diabetes mellitus (GDM) in women who had OGCT >or=200 mg/dl and fasting hyperglycemia.Study design A retrospective study was performed among a subset of women treated with glyburide or insulin for GDM from 1999 to 2002 with an OGCT >or=200 mg/dl and pretreatment fasting plasma glucose >or=105 mg/dl. Exclusion criteria included pretreatment fasting >or=140 mg/dl, gestational age >or=34 weeks and multiple gestation. Maternal and neonatal outcomes were assessed. Statistical methods included bivariate and multivariable logistic regression analyses.Results In 1999 to 2000, 78 women were treated with insulin; in 2001 to 2002, 44 of 69 (64%) received glyburide. There were no statistically significant differences between the two groups with regards to mean OGCT (230+/-25 vs 223+/-23 mg/dl, P=0.07) and mean pretreatment fasting (120+/-10 vs 119+/-11 mg/dl, P=0.45). Seven women (16%) failed glyburide. Women in the insulin group were younger (31.5+/-5.8 vs 35.2+/-4.7 years, P<0.001) and had a higher mean BMI (32.4+/-6.4 vs 29.1+/-5.8 kg/m(2), P=0.003) compared to glyburide group. There were no significant differences in birth weight (3524+/-548 vs 3420+/-786 g, P=0.65), macrosomia (19 vs 23%, P=0.65), pre-eclampsia (12 vs 11%, P=0.98) or cesarean delivery (39 vs 46%, P=0.45). Neonates in the glyburide group were diagnosed more frequently with hypoglycemia (34 vs 14%, P=0.01). When controlled for confounders, macrosomia was found to be associated with glyburide treatment (OR 3.5, 95% CI 1.1 to 11.4).Conclusion In women with GDM who had a markedly elevated OGCT and fasting hyperglycemia, glyburide achieved similar birth weights and delivery outcomes but was associated with an increased risk of macrosomia. The possible increased risk of neonatal hypoglycemia in the glyburide group warrants further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
RetractedAn analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Management of diabetes mellitus complicating pregnancy
Gabbe, S. (2003) · Obstetrics & Gynecology · doi:10.1016/j.obstetgynecol.2003.07.001 · Cited by 329
Jacobson, G. F., Ramos, G. A., Ching, J. Y., Kirby, R. S., Ferrara, A., & Field, D. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.018 · Cited by 177
Self-citationManagement of Diabetes Mellitus by Obstetrician–Gynecologists
Gabbe, S. G., Gregory, R. P., Power, M. L., Williams, S. B., & Schulkin, J. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000128045.50439.89 · Cited by 141
Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome
Langer, O., Yogev, Y., Xenakis, E. M.-J., & Rosenn, B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.07.011 · Cited by 140
Perucchini, D., Fischer, U., Spinas, G. A., Huch, R., Huch, A., & Lehmann, R. (1999) · BMJ · doi:10.1136/bmj.319.7213.812 · Cited by 124
Chmait, R., Dinise, T., & Moore, T. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211147 · Cited by 118
Research works printed but not linked: 2
- Metzger BE, Coustan DR . Summary of recommendations of the Fourth International Workshop–Conference on gestational diabetes mellitus. Diabetes care 1998; 21 (S2): 161–167.
- Gilson G, Murphy N . Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska Native women. Am J Obstet Gynecol 2002; 187 (6): S152.
Cited by
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
Camelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.74 · Cited by 177
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
Camelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000285 · Cited by 118
The management of gestational diabetes
Cheung, W. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3405 · Cited by 110
Gestational diabetes mellitus: challenges in diagnosis and management
Mpondo, B. C. T., Ernest, A. I., & Dee, H. E. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0169-7 · Cited by 86
“Studies examining the use of glyburide and insulin for the management of GDM have found comparative maternal and neonatal outcomes [45, 46].”
BackgroundComparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis
Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182488 · Cited by 73
Glyburide as treatment option for gestational diabetes mellitus
Tempe, A., & Mayanglambam, R. D. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12042 · Cited by 71
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
Waugh, N., Royle, P., Clar, C., Henderson, R., Cummins, E., Hadden, D., Lindsay, R., & Pearson, D. (2010) · Health Technology Assessment · doi:10.3310/hta14450 · Cited by 60
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Malek, R., & Davis, S. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1187131 · Cited by 54
“This study investigated women treated with glyburide (n = 78) and compared them to women treated with insulin (n = 44) in the 2 years prior with regard to glycemic control and neonatal outcomes.[44] Sixteen percent of women treated with glyburide were switched to insulin, and these women tended to have higher fasting…”
ResultUpdate on Gestational Diabetes
Pridjian, G. C., & Benjamin, T. D. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.017 · Cited by 66
The use of oral hypoglycaemic agents in pregnancy
Holt, R. I. G., & Lambert, K. D. (2014) · Diabetic Medicine · doi:10.1111/dme.12376 · Cited by 50
Oral hypoglycemic agents for gestational diabetes mellitus?
Maymone, A. C., Baillargeon, J.-P., Ménard, J., & Ardilouze, J.-L. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.521740 · Cited by 41
“5) and hypoglycemia (34 vs 14%) were increased with glyburide treatment in three studies including only 54, 122 and 68 women, respectively [43-45].”
BackgroundSaberi, F., Behrashi, M., Samimi, M., Ghasemi, T., & Atoof, F. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.184502 · Cited by 37
“,[14] hypoglycemia was significantly higher in the glibenclamide group than the insulin group.”
BackgroundResultInfluentialWang, J., Wang, X., Li, Q., Huang, H., Zheng, Q.-L., Yao, Q., & Zhang, J. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01305-6 · Cited by 32
“All the management decisions were based on existing guidelines [6, 23].”
BackgroundTreating diabetes during pregnancy
Klein, J., Charach, R., & Sheiner, E. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.988140 · Cited by 27
“However there was an increased risk of macrosomia associated with those in the glyburide treatment group [54].”
BackgroundThe effectiveness of glibenclamide in women with gestational diabetes
Holt, R. I. G., Clarke, P., Parry, E. C., & Coleman, M. A. G. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00828.x · Cited by 25
Is Glyburide Safe in Pregnancy?
Kimber-Trojnar, Ż., Marciniak, B., Patro-Małysza, J., Skórzyńska-Dziduszko, K., Poniedziałek‐Czajkowska, E., Mierzyński, R., Gałczyński, K., Trojnar, M. P., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140330200254 · Cited by 20
“These studies included randomized prospective trials [11, 76, 93-98], prospective observational studies [16, 99-106], and retrospective studies [107-114], and show that glyburide seems unlikely to negatively influence the fetus [60, 115-117].”
MethodGlyburide for the treatment of gestational diabetes mellitus.
Kimber-Trojnar, Ż., Marciniak, B., Leszczyńska‐Gorzelak, B., Trojnar, M. P., & Oleszczuk, J. (2008) · PubMed · Cited by 21
Helal, K. F., Badr, M. S., Rafeek, M. E.-S., Elnagar, W. M., & Lashin, M. E.-B. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05430-3 · Cited by 17
Pharmacological Management of Gestational Diabetes Mellitus
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0802-y · Cited by 19
Thomas, N., Jyothirmayi, C. A., Sridhar, S., Kumar, M., Kuruvilla, K. A., & Jana, A. K. (2012) · Indian Pediatrics · doi:10.1007/s13312-013-0096-y · Cited by 13
Using Oral Agents to Manage Gestational Diabetes: What Have We Learned?
Buschur, E., Brown, F. M., & Wyckoff, J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0570-5 · Cited by 10
Magdy, M. (2014) · Gynecology & Obstetrics · doi:10.4172/2161-0932.1000193 · Cited by 10
“in their retrospective studies comparing glibenclamide and insulin; as regard maternal blood glucose [14,15].”
BackgroundCan Pregnant Diabetics be Treated with Glyburide?
Melamed, N., & Yogev, Y. (2009) · Women s Health · doi:10.2217/whe.09.55 · Cited by 9
“, few studies reported a higher rate of neo‐ natal complications in patients treated with gly‐ buride, including neonatal hypoglycemia [33,42], LGA infants and macrosomia [31,33,34,42], small for gestational age (SGA) infants [34], need for phototherapy [32] and longer NICU stay [32].”
BackgroundFaraji, A., Tahamtani, L., Maharlouei, N., & Asadi, N. (2022) · Obstetric Medicine · doi:10.1177/1753495x221100167 · Cited by 7
“13–18 While some recent studies have demonstrated equal results of glucose control with glibenclamide and insulin,(13,17) some others believe that insulin remains the treatment of choice.(11,16,18) In addition, most of the previously conducted studies have focused on the serum glucose level control, and few of them ha…”
ResultRosenn, B. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903550873 · Cited by 8
“In fact, the rates of macrosomia and LGA were, in most instances, strikingly similar whether women were treated with glyburide or insulin [1,8,10,11].”
ResultTraitement du diabète gestationnel par hypoglycémiants oraux
Carles, G., Germain, L., Alassas, N., Guindi, W. E., Dallah, F., & Daigre, J.-L. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2009.12.002 · Cited by 9
Gestational diabetes mellitus: what is the optimal treatment modality?
Cheng, Y. W., & Caughey, A. B. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211737 · Cited by 8
Oral hypoglycemic agents: do the ends justify the means?
Langer, O. (2015) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-015-0021-6 · Cited by 5
“Ramos’07 [43] Retrospective 122”
Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy
Shmuel, E., Krispin, E., Toledano, Y., Chen, R., Wiznitzer, A., & Hadar, E. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1875208 · Cited by 7
Treatment Considerations for Gestational Diabetes Mellitus and Long-Term Postpartum Options
Radenkovi, M. (2011) · InTech eBooks · doi:10.5772/21908 · Cited by 4
“However, it has to be emphasized that in some investigations a glyburide-related increased risk of preeclampsia, macrosomia, neonatal hypoglycemia, admission to a neonatal intensive care unit; as well a need for phototherapy have been reported (Jacobson et al., 2005; Ramos et al., 2007).”
Background7. Management of hyperglycemia during pregnancy
(2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30015-1 · Cited by 3
Diabetes in pregnancy: current ways of treatment
Bartášková, D. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.044 · Cited by 2
Oral antidiabetic agents in gestational diabetes: a narrative review of current evidence
Singh, A. K., & Singh, R. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.982090 · Cited by 2
“4) when controlled for confounders [33]”
BackgroundInfluentialGlyburide Is a Safe and Effective Treatment for Gestational Diabetes
Kelly, L. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32733-5 · Cited by 2
Glyburide Disposition During Pregnancy
Diana, L., Mary, F., & Mao, Q. (2011) · InTech eBooks · doi:10.5772/20926 · Cited by 1
“There were no significant differences in fetal outcomes between the two treatment groups; however, the incidence of neonatal hypoglycemia was higher in glyburide-treated women (34% versus 15%, respectively) (Ramos et al., 2007).”
BackgroundMethodInfluentialEFFECT OF CINNAMOMUM ZEYLANICUM AND SYZYGIUM CUMINI ON GESTATIONAL DIABETIC RATS
Rekha, N. (2010) · Cited by 1
Nutritional Management for Gestational Diabetes
Duarte‐Gardea, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00033-0 · Cited by 1
Neonatal Outcomes in Gestational Diabetes Mellitus
Rashed, G. M., ALOmrani, A. A. A., Mohmmed, Z. A., & Albahadle, A. K. J. (2022) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.20.1.8
Wang, J.-J., Wang, X., Li, Q., Huang, H., Zheng, Q., Yao, Q., & Zhang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26570686
Metadata
- Authors
- Ramos, G. A., Jacobson, G. F., Kirby, R. S., Ching, J. Y., & Field, D. R.
- Affiliations
- University of California San Diego (US)
- Kaiser Permanente Northern California (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Ramos, G A
- ORCID
- Venue
- Journal of Perinatology
- Published
- 2007-03-15
- Volume
- 27
- Issue
- 5
- Pages
- 262-267
- ISSN
- 0743-8346 (ISSN-L)
- 1476-5543
- OpenAlex
- W1971523683
- Cited by
- 44
- References
- 17
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 4 · 2012: 2
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Perinatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glibenclamide, insulin therapy, oral glucose challenge test, fasting hyperglycemia, glycemic control, neonatal hypoglycemia, macrosomia, birth weight, preeclampsia, cesarean section, maternal outcomes, treatment failure, sulfonylureas, insulin therapy in pregnancy, maternal obesity, maternal age, body mass index
- MeSH terms
- Adult, Combined Modality Therapy, Diet, Diabetic, Female, Fetal Macrosomia, Glyburide, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Obstetric Labor, Premature, Pregnancy, Pregnancy Outcome, Retrospective Studies, Blood Glucose Self-Monitoring, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.